2015
DOI: 10.1007/978-3-319-15630-9_7
|View full text |Cite
|
Sign up to set email alerts
|

Diabetes and Tryptophan Metabolism

Abstract: Tryptophan, an essential amino acid, can be metabolized to several kinds of physiologically active metabolites. Accumulating data indicate that an altered metabolism of tryptophan and its active metabolites have important roles for the pathogenesis and development of complications of diabetes mellitus. Changes in tryptophan-kynurenine and tryptophan-methoxyindole pathways are related to several pathophysiological mechanisms of type 1 or type 2 diabetes. Particularly, serotonin, melatonin, and their receptors w… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

1
11
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 16 publications
(12 citation statements)
references
References 164 publications
(88 reference statements)
1
11
0
Order By: Relevance
“…Tryptophan can be metabolized to several kinds of physiologically active metabolites such as kynurenine, kynurenic acid, and serotonin via two metabolic pathways: tryptophan–kynurenine and tryptophan–methoxyindole. The changes in the two pathways have been related to several pathophysiological mechanisms of type 2 diabetes [23].…”
Section: Discussionmentioning
confidence: 99%
“…Tryptophan can be metabolized to several kinds of physiologically active metabolites such as kynurenine, kynurenic acid, and serotonin via two metabolic pathways: tryptophan–kynurenine and tryptophan–methoxyindole. The changes in the two pathways have been related to several pathophysiological mechanisms of type 2 diabetes [23].…”
Section: Discussionmentioning
confidence: 99%
“…IDO1, a rate-limiting enzyme for the conversion of tryptophan to kynurenine, is upregulated in response to inflammatory cytokines (29) and may act as a local compensatory mechanism to limit obesity-induced inflammation (30). Thus, in inflammatory states such as obesity, the tryptophan–kynurenine pathway may shift in favor of breakdown of tryptophan into downstream products (31, 32). This hypothesis is supported by our finding that the baseline Kyn/Trp ratio was positively associated with insulin resistance but that 1-year changes in the same ratio was inversely associated with insulin resistance.…”
Section: Discussionmentioning
confidence: 99%
“…Second, the amount of dietary Trp destined for central 5-HT is also limited. Only a small portion of Trp consumed is metabolized via the methoxyindole pathway for 5-HT synthesis due to competition with the more dominant kynurenine pathway, as well as protein synthesis, and alternative metabolites such as melatonin and tryptamine [10, 46, 47]. Most of this 5-HT pool is synthesized in the gut, reserving a small and controlled amount for the CNS [10, 48].…”
Section: Discussionmentioning
confidence: 99%
“…Yet central 5-HT stores cannot be inferred from dietary Trp and LNAA content alone. Trp availability and transport for central 5-HT is also dictated by other factors: health conditions or medications causing Trp malabsorption [46]; excess Trp oxidation or metabolism [47, 4951] changes in the kynurenine pathway [47, 52]; changes in peripheral 5-HT production [52, 53]; changes in gut microbiota [53]; chronic inflammation [54, 55]; and prolonged stress [51, 56, 57].…”
Section: Discussionmentioning
confidence: 99%